If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
8.02    0.00 (0.00%)
Bid:
7.90
Ask:
8.50
Spread: 0.60 (7.595%)
Market Cap: £92.69m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Director/PDMR Shareholding

4 Dec 2015 11:58

RNS Number : 0666I
SIG PLC
04 December 2015
 



 

 

SIG plc

4 December 2015

Ordinary Shares of 10p each

 

Pursuant to DTR 3.1.4 and following a notification received on 4 December 2015 in fulfilment of the obligations imposed by DTR 3.1.2 we hereby announce that the following award has been granted to a PDMR.

 

SIG plc (the "Company") announces that on 4 December 2015, a "phantom award" was granted in respect of 206,819 ordinary shares to Mr Christian Horn (Group Operations Director). This phantom award is granted on terms equivalent to the LTIP awards granted on 17 September 2015 and subject to the same performance conditions, but is a right to receive a cash sum calculated by reference to the value of the relevant number of shares on vesting, and gives no right to the shares themselves.

 

Subject to the rules of the LTIP and the satisfaction of the performance conditions detailed below, the earliest vesting date of the award is normally 3 December 2018.

 

The performance conditions subject to which the options have been granted are as follows:

 

1. Two thirds of the award is subject to a condition as to the average return on capital employed (ROCE) over the Performance Period (the "ROCE Tranche"). The period over which the ROCE performance condition will be measured will be the period of three financial years 31 December 2015, 2016 and 2017.

Average Return on Capital Employed (ROCE) for FY2015-2017

% of ROCE Tranche vesting

11% or less

Nil

Above 11% but less than 14%

Between 0% and 100% on astraight-line basis

14% and above

100%

 

2. The remaining one third of the award is subject to a condition as to the cumulative underlying earnings per share (EPS) over the Performance Period (the "EPS Tranche"). The period over which the EPS performance condition will be measured will be the period of three financial years 31 December 2015, 2016 and 2017.

Cumulative Underlying EPS forFY2015-2017

% of EPS Tranche vesting

Less than 38 pence

Nil

38 pence to 48 pence

25% to 100% on astraight-line basis

Above 48 pence

100%

 

R C Monro

Company Secretary 0114 285 6355

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFSWFFLFISEIE
Date   Source Headline
30th Jan 20255:02 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS2024 Full Year Trading Update
27th Nov 20242:45 pmRNSHolding(s) in Company
27th Nov 20242:39 pmRNSHolding(s) in Company
25th Nov 20248:00 amRNSPost Stabilisation Notice
23rd Oct 202410:14 amRNSFinal Result of the Tender Offer – Existing Notes
18th Oct 20247:00 amRNSPricing of €300,000,000 Senior Secured Notes
16th Oct 202412:28 pmRNSPre Stabilisation Notice
14th Oct 20247:04 amRNSProposed Refinancing Transactions
10th Oct 20247:43 amRNSResponse to press speculation
2nd Oct 20247:00 amRNSQ3 Trading Update
12th Sep 20245:07 pmRNSHolding(s) in Company
6th Aug 20247:00 amRNSResults for the six months to 30 June 2024
24th Jun 20247:00 amRNSTrading Update
2nd May 20241:53 pmRNSResult of AGM
2nd May 20247:00 amRNSTrading Update
12th Apr 20244:01 pmRNSDirector/PDMR Shareholding
4th Apr 202410:12 amRNSDirector/PDMR Shareholding
25th Mar 202410:21 amRNSNotice of AGM
22nd Mar 202410:30 amRNSDirector/PDMR Shareholding
22nd Mar 202410:12 amRNSDirector/PDMR Shareholding
5th Mar 202412:14 pmRNSAnnual Financial Report
5th Mar 20247:00 amRNSFull year results for year ended 31 December 2023
9th Jan 20247:00 amRNS2023 Full Year Trading Update
1st Dec 20235:42 pmRNSDirector/PDMR Shareholding
23rd Nov 20239:00 amRNSCapital Markets Event
13th Nov 20239:00 amRNSNotice of Capital Markets Event
13th Oct 20233:51 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSQ3 Trading Update
25th Sep 20233:56 pmRNSDirectorate Change
9th Aug 20234:58 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSHalf-year Report
12th Jul 20234:26 pmRNSHolding(s) in Company
11th Jul 20234:06 pmRNSHolding(s) in Company
11th Jul 202310:58 amRNSHolding(s) in Company
10th Jul 202311:09 amRNSHolding(s) in Company
5th Jul 20233:15 pmRNSHolding(s) in Company
5th Jul 20237:00 amRNSH1 Trading Update
4th May 20232:32 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Update
31st Mar 202312:47 pmRNSHolding(s) in Company
27th Mar 202310:30 amRNSNotice of AGM
13th Mar 20233:49 pmRNSDirector/PDMR Shareholding
13th Mar 20233:39 pmRNSDirector/PDMR Shareholding
13th Mar 202310:36 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSDirector/PDMR Shareholding
8th Mar 20231:20 pmRNSAnnual Financial Report
8th Mar 20237:01 amRNSDirectorate Changes
8th Mar 20237:00 amRNSFull year results for the year ended 31 Dec 2022
27th Feb 202311:20 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.